Arteriosclerosis, Vol 9, 33-42, Copyright © 1989 by American Heart Association
ARTICLES |
KS Sakariassen and HR Baumgartner
Department of Pharmaceutical Research, F. Hoffmann-La Roche & Company, Basel, Switzerland.
Vascular subendothelium and collagenous surfaces were exposed to flowing citrated blood. Platelet interactions with these surfaces were investigated at various axial distances from the upstream end of the exposed surfaces. A pronounced axial decrease in surface coverage with platelets and in thrombus dimensions was encountered on collagenous surfaces. This phenomenon was observed at shear rates of 200 to 2000 s- 1, but was most pronounced at low shear rates (less than 650 s-1). After 5 minutes of perfusion at a shear rate of 650 s-1, 4.6 x 10(6) platelets were deposited on the most upstream 20 mm2 of the collagen surface, in contrast to 2.2 x 10(6) platelets/20 mm2 14 mm farther downstream. Depletion of von Willebrand factor and/or thrombospondin from the boundary layer of the blood flow was not responsible for this. Collagen-bound von Willebrand factor enhanced the surface coverage with platelets without affecting the axial decrement, while pretreatment of the collagen surface with thrombospondin had no effect at all. However, partial inhibition of thrombus growth by aspirin reduced the axial decrements, and less thrombogenic surfaces as human and rabbit subendothelium, which induced only a few small thrombi, produced virtually no axial differences in platelet adhesion. Raising the shear rate to 2600 s-1 also gave no axial differences in platelet-collagen adhesion; it did, however, give an axial increase in thrombus dimensions. This increase was neutralized after the addition of antibody against human platelet thrombospondin to the blood.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
J.-P. Bossavy, C. Thalamas, L. Sagnard, A. Barret, K. Sakariassen, B. Boneu, and Y. Cadroy A Double-Blind Randomized Comparison of Combined Aspirin and Ticlopidine Therapy Versus Aspirin or Ticlopidine Alone on Experimental Arterial Thrombogenesis in Humans Blood, September 1, 1998; 92(5): 1518 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Andre, B. Arbeille, V. Drouet, P. Hainaud, C. Bal dit Sollier, J. P. Caen, and L. O. Drouet Optimal Antagonism of GPIIb/IIIa Favors Platelet Adhesion by Inhibiting Thrombus Growth : An Ex Vivo Capillary Perfusion Chamber Study in the Guinea Pig Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 56 - 63. [Abstract] [Full Text] |
||||
![]() |
M. M. Hussain, T. L. Innerarity, W. J. Brecht, and R. W. Mahley Chylomicron Metabolism in Normal, Cholesterol-fed, and Watanabe Heritable Hyperlipidemic Rabbits J. Biol. Chem., April 14, 1995; 270(15): 8578 - 8587. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Barstad, M. J. A. G. Hamers, P. Kierulf, A.-B. Westvik, and K. S. Sakariassen Procoagulant Human Monocytes Mediate Tissue Factor/Factor VIIa–Dependent Platelet-Thrombus Formation When Exposed to Flowing Nonanticoagulated Human Blood Arterioscler. Thromb. Vasc. Biol., January 1, 1995; 15(1): 11 - 16. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |